UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Acquired Haemophilia A. Which is the best therapeutic choice in older adults? Single center study of 4 cases

Reumatismo, 2019-04, Vol.71 (1), p.37-41

2019

Volltextzugriff (PDF)

Real life of DAAs (direct antiviral agents) for HCV infection in Friuli Venezia Giulia: Who, why, what, how did we treat?

Digestive and liver disease, 2016-10, Vol.48, p.e238-e238

2016

Volltextzugriff (PDF)

Direct acting antiviral (DAA) therapy of HCV, effects on the cryoglobulinemic vasculitis: A multi center open label study

Digestive and liver disease, 2017-02, Vol.49 (1), p.e32-e32

2017

Volltextzugriff (PDF)

P.249 CONSCIOUS SEDATION DURING ENDOSCOPY RETROGRADE COLANGIOPANCREATOGRAPHY: NEW MODEL WITH GASTROENTEROLOGIST ASSISTED BY AN ANESTHESIA NURSE IN BELLUNO HOSPITAL

Digestive and liver disease, 2010, Vol.42, p.S189-S189

2010

Volltextzugriff (PDF)

Thrombocytopenia associated with Acute Hepatitis B

Acta gastro-enterologica belgica, 2016-09, Vol.79 (4), p.405

2016

Volltextzugriff (PDF)

Management of infectious mixed cryoglobulinemia: Clinical outcome of 246 patients

Digestive and liver disease, 2014-02, Vol.46, p.e18-e18

2014

Volltextzugriff (PDF)

809 INCREASED RISK OF HEPATOCELLULAR CARCINOMA AND THERAPY OF TYPE 2 DIABETES MELLITUS

Journal of hepatology, 2009, Vol.50, p.S296-S296

2009

Volltextzugriff (PDF)

Long-term effects of the new direct antiviral agents (DAAs) therapy for HCV-related mixed cryoglobulinaemia without renal involvement: a multicentre open-label study

Clinical and experimental rheumatology, 2018-03, Vol.36 Suppl 111 (2), p.107

2018

Volltextzugriff (PDF)

Hepatitis Viruses, Alcohol, and Tobacco in the Etiology of Hepatocellular Carcinoma in Italy

Cancer epidemiology, biomarkers & prevention, 2006-04, Vol.15 (4), p.683-689

2006

Volltextzugriff (PDF)

Efficacy of a second cycle of interferon therapy in patients with chronic hepatitis C

Gastroenterology (New York, N.Y. 1943), 1997-11, Vol.113 (5), p.1654-1659

1997

Volltextzugriff (PDF)

Thrombocytopenia associated with Acute Hepatitis B

Acta gastro-enterologica belgica, 2016-09, Vol.79 (4), p.405

2016

Volltextzugriff (PDF)

Treatment with interferon(s) of community-acquired chronic hepatitis and cirrhosis type C

Journal of hepatology, 1993, Vol.17, p.S123-S126

1993

Volltextzugriff (PDF)

Predictors of sustained response, relapse and no response in patients with chronic hepatitis C treated with interferon-α

Journal of viral hepatitis, 1995-01, Vol.2 (2), p.91-96

1995

Volltextzugriff (PDF)

Alcohol and HCV chronic infection are risk cofactors of type 2 diabetes mellitus for hepatocellular carcinoma in Italy

International journal of environmental research and public health, 2010-04, Vol.7 (4), p.1366-1378

2010

Volltextzugriff (PDF)

Comparison of thrice weekly vs daily human leucocyte interferon-α therapy for chronic hepatitis C

Journal of viral hepatitis, 1999-07, Vol.6 (4), p.321-327

1999

Volltextzugriff (PDF)

280 Diabetes mellitus accellerates the development of hepatocellular carcinoma (HCC) in alcohol-related but not in virus-related chronic liver disease

Journal of hepatology, 2006-04, Vol.44, p.S110-S110

2006

Volltextzugriff (PDF)

Treatment of chronic hepatitis C with interferon-α by monitoring the response according to viraemia

Journal of viral hepatitis, 1997-03, Vol.4 (2), p.107-112

1997

Volltextzugriff (PDF)

The pattern of response to interferon alpha (α-IFN) predicts sustained response to a 6-month α-IFN and ribavirin retreatment for chronic hepatitis C

Journal of hepatology, 2000-07, Vol.33 (1), p.128-134

2000

Volltextzugriff (PDF)

Patterns of antibodies to hepatitis C virus in patients with chronic non‐A, non‐B hepatitis and their relationship to viral replication and liver disease

Hepatology (Baltimore, Md.), 1993-02, Vol.17 (2), p.179-182

1993

Volltextzugriff (PDF)

Liver fibrosis regression after α-IFN and ribavirin combination therapy for chronic hepatitis C (CHC): a 6 year prospective-observational study

Journal of hepatology, 2001-04, Vol.34, p.145-145

2001

Volltextzugriff (PDF)

The pattern of response to interferon alpha (alpha-IFN) predicts sustained response to a 6-month alpha-IFN and ribavirin retreatment for chronic hepatitis C. TVVH Study Group

Journal of hepatology, 2000-07, Vol.33 (1), p.128

2000

Volltextzugriff (PDF)

Retreatment of chronic hepatitis C (CHC) with sequential interferon-ribavirin combination (IFN-RIBA) therapy

Journal of hepatology, 1998, Vol.28, p.109-109

1998

Volltextzugriff (PDF)

Randomized trial comparing three different regimens of alpha‐2a‐interferon in chronic hepatitis C

Hepatology (Baltimore, Md.), 1995-09, Vol.22 (3), p.700-706

1995

Volltextzugriff (PDF)

Jaundice and cholestasis: past, present and future ideas

The Italian journal of gastroenterology, 1990-08, Vol.22 (4), p.214

1990

Volltextzugriff (PDF)

Comparison of thrice weekly vs daily human leucocyte interferon-alpha therapy for chronic hepatitis C. TVVH Study Group

Journal of viral hepatitis, 1999-07, Vol.6 (4), p.321-327

1999

Volltextzugriff (PDF)

1 – 25 von 201

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(166)
Mit Volltextzugriff
(170)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Acquired Haemophilia A. Which is the best therapeutic choice in older adults? Single center study of 4 cases

Real life of DAAs (direct antiviral agents) for HCV infection in Friuli Venezia Giulia: Who, why, what, how did we treat?

Direct acting antiviral (DAA) therapy of HCV, effects on the cryoglobulinemic vasculitis: A multi center open label study

P.249 CONSCIOUS SEDATION DURING ENDOSCOPY RETROGRADE COLANGIOPANCREATOGRAPHY: NEW MODEL WITH GASTROENTEROLOGIST ASSISTED BY AN ANESTHESIA NURSE IN BELLUNO HOSPITAL

Thrombocytopenia associated with Acute Hepatitis B

Management of infectious mixed cryoglobulinemia: Clinical outcome of 246 patients

809 INCREASED RISK OF HEPATOCELLULAR CARCINOMA AND THERAPY OF TYPE 2 DIABETES MELLITUS

Long-term effects of the new direct antiviral agents (DAAs) therapy for HCV-related mixed cryoglobulinaemia without renal involvement: a multicentre open-label study

Hepatitis Viruses, Alcohol, and Tobacco in the Etiology of Hepatocellular Carcinoma in Italy

Efficacy of a second cycle of interferon therapy in patients with chronic hepatitis C

Thrombocytopenia associated with Acute Hepatitis B

Treatment with interferon(s) of community-acquired chronic hepatitis and cirrhosis type C

Predictors of sustained response, relapse and no response in patients with chronic hepatitis C treated with interferon-α

Alcohol and HCV chronic infection are risk cofactors of type 2 diabetes mellitus for hepatocellular carcinoma in Italy

Comparison of thrice weekly vs daily human leucocyte interferon-α therapy for chronic hepatitis C

280 Diabetes mellitus accellerates the development of hepatocellular carcinoma (HCC) in alcohol-related but not in virus-related chronic liver disease

Treatment of chronic hepatitis C with interferon-α by monitoring the response according to viraemia

The pattern of response to interferon alpha (α-IFN) predicts sustained response to a 6-month α-IFN and ribavirin retreatment for chronic hepatitis C

Patterns of antibodies to hepatitis C virus in patients with chronic non‐A, non‐B hepatitis and their relationship to viral replication and liver disease

Liver fibrosis regression after α-IFN and ribavirin combination therapy for chronic hepatitis C (CHC): a 6 year prospective-observational study

The pattern of response to interferon alpha (alpha-IFN) predicts sustained response to a 6-month alpha-IFN and ribavirin retreatment for chronic hepatitis C. TVVH Study Group

Retreatment of chronic hepatitis C (CHC) with sequential interferon-ribavirin combination (IFN-RIBA) therapy

Randomized trial comparing three different regimens of alpha‐2a‐interferon in chronic hepatitis C

Jaundice and cholestasis: past, present and future ideas

Comparison of thrice weekly vs daily human leucocyte interferon-alpha therapy for chronic hepatitis C. TVVH Study Group

Suchergebnisse filtern